Biovica International AB Namn-Aktier o.N.

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

36.54%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.03 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.035 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 05:02:33 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.0360.027
PREV. DAY'S PRICE0.033 (07/20)
CHANGE DAY BEFORE
+0.00
6.06 %
52 WEEK HIGH / LOW0.0584 (02/16)0.0074 (02/11)

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-0.17-0.08-0.03--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
1.391.581.18--
PRICE - SALES RATIO
12.777.526.14--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A2DPS4
ISIN
SE0008613731
SYMBOL
9II
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
BIOVICA INTERNATIONAL
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
10.00 %
42.24 %
6.45 %
258.70 %
-36.54 %
-91.86 %
-99.34 %
19.57 %
HIGH0.040.040.040.060.060.765.910.06
LOW0.030.010.010.010.010.010.010.01

Dividende

pro Aktie
BIOVICA INTERNATIONAL does not deliver dividend information

Company profile

Biovica International AB is engages in the development and commercialization of novel blood-based biomarker assays to improve the monitoring of modern cancer therapies. It offers DiviTum assay, which is intended to monitor and predict treatment response in cancer patients. The company was founded in 2009 and is headquartered in Uppsala, Sweden.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.